This article was originally published in The Tan Sheet
Daily doses of 75 mg-150 mg per day reduce risk of vascular events by 32% in high-risk patients, according to meta-analysis by Antithrombotic Trialists' Collaboration (Oxford, England) in Jan. 12 British Medical Journal. C. Baigent, et al., reviewed a total of 287 studies involving 212,000 patients that compared antiplatelet therapy with either controls or other antiplatelet regimens. Accompanying editorial by John Cleland, University of Hull, maintains aspirin efficacy is overstated since it does not reduce mortality...
You may also be interested in...
A "definitively positive trial" on aspirin's effectiveness at lowering mortality due to coronary heart disease is still needed, John Cleland, University of Hull, UK, states in an editorial in the Jan. 12 British Medical Journal
A study with nearly 500 patients with vitamin D levels tested within a year before receiving COVID-19 tests found subjects deficient in the nutrient had 1.77 greater chance of testing positive. Researchers say RCTs are needed to determine if broad population interventions are necessary.
The company is running a pilot program to allow glioblastoma patients who use Novocure’s Optune Tumor Treating Fields device to download data from the device at home.